nodes	percent_of_prediction	percent_of_DWPC	metapath
Isotretinoin—RARB—lung cancer	0.63	1	CbGaD
Isotretinoin—RARA—mammary gland—lung cancer	0.00264	0.136	CbGeAlD
Isotretinoin—RARB—respiratory system—lung cancer	0.00229	0.118	CbGeAlD
Isotretinoin—RARB—bronchus—lung cancer	0.00189	0.0975	CbGeAlD
Isotretinoin—RARG—respiratory system—lung cancer	0.00187	0.0967	CbGeAlD
Isotretinoin—RARA—respiratory system—lung cancer	0.00176	0.0909	CbGeAlD
Isotretinoin—Acitretin—RARB—lung cancer	0.00159	0.279	CrCbGaD
Isotretinoin—Alitretinoin—RARB—lung cancer	0.00153	0.267	CrCbGaD
Isotretinoin—RXRB—cardiac atrium—lung cancer	0.00146	0.0756	CbGeAlD
Isotretinoin—RARB—lung—lung cancer	0.00122	0.0629	CbGeAlD
Isotretinoin—RXRB—lung—lung cancer	0.00112	0.0578	CbGeAlD
Isotretinoin—Tretinoin—RARB—lung cancer	0.00108	0.188	CrCbGaD
Isotretinoin—RARA—bone marrow—lung cancer	0.00103	0.0533	CbGeAlD
Isotretinoin—RARG—lung—lung cancer	0.000993	0.0513	CbGeAlD
Isotretinoin—RARA—lung—lung cancer	0.000933	0.0483	CbGeAlD
Isotretinoin—RARB—lymph node—lung cancer	0.000832	0.043	CbGeAlD
Isotretinoin—RARG—lymph node—lung cancer	0.000679	0.0351	CbGeAlD
Isotretinoin—RARA—lymph node—lung cancer	0.000638	0.033	CbGeAlD
Isotretinoin—Tretinoin—CYP2A6—lung cancer	0.000431	0.0753	CrCbGaD
Isotretinoin—Vitamin A—CYP1A1—lung cancer	0.000313	0.0546	CrCbGaD
Isotretinoin—Tretinoin—CYP1A1—lung cancer	0.000302	0.0528	CrCbGaD
Isotretinoin—Acitretin—ALB—lung cancer	0.000249	0.0435	CrCbGaD
Isotretinoin—Alitretinoin—ABCB1—lung cancer	0.000228	0.0398	CrCbGaD
Isotretinoin—RARG—Gene Expression—NPPA—lung cancer	7.22e-05	0.000609	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	7.09e-05	0.000598	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	7.07e-05	0.000596	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	7.04e-05	0.000593	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—RB1—lung cancer	7e-05	0.00059	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	6.97e-05	0.000588	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—RARB—lung cancer	6.9e-05	0.000581	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.84e-05	0.000577	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AZIN2—lung cancer	6.8e-05	0.000573	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—COL4A3BP—lung cancer	6.8e-05	0.000573	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—RARB—lung cancer	6.78e-05	0.000571	CbGpPWpGaD
Isotretinoin—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—lung cancer	6.75e-05	0.000569	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	6.75e-05	0.000569	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NPPA—lung cancer	6.72e-05	0.000567	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.66e-05	0.000562	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—HNRNPA2B1—lung cancer	6.63e-05	0.000559	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NPPA—lung cancer	6.61e-05	0.000557	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.56e-05	0.000553	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NPPA—lung cancer	6.48e-05	0.000546	CbGpPWpGaD
Isotretinoin—RXRA—Organelle biogenesis and maintenance—CREBBP—lung cancer	6.44e-05	0.000543	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	6.42e-05	0.000541	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—lung cancer	6.4e-05	0.000539	CbGpPWpGaD
Isotretinoin—RXRG—Adipogenesis—IL6—lung cancer	6.39e-05	0.000539	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.39e-05	0.000539	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—RARB—lung cancer	6.37e-05	0.000537	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—RARB—lung cancer	6.37e-05	0.000537	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ABCC3—lung cancer	6.34e-05	0.000534	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—SOX2—lung cancer	6.33e-05	0.000533	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.3e-05	0.000531	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NPPA—lung cancer	6.21e-05	0.000523	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—HSPB1—lung cancer	6.21e-05	0.000523	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NPPA—lung cancer	6.21e-05	0.000523	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—AKR1C1—lung cancer	6.14e-05	0.000518	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.13e-05	0.000517	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—KHSRP—lung cancer	6.06e-05	0.000511	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.04e-05	0.00051	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCC3—lung cancer	6.03e-05	0.000508	CbGpPWpGaD
Isotretinoin—RARA—Adipogenesis—IL6—lung cancer	6.01e-05	0.000507	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6e-05	0.000506	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCOA3—lung cancer	5.95e-05	0.000501	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	5.88e-05	0.000496	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NCAM1—lung cancer	5.79e-05	0.000488	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ATP5H—lung cancer	5.78e-05	0.000487	CbGpPWpGaD
Isotretinoin—RXRA—Biological oxidations—POMC—lung cancer	5.76e-05	0.000486	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.75e-05	0.000485	CbGpPWpGaD
Isotretinoin—RARG—Generic Transcription Pathway—CREBBP—lung cancer	5.72e-05	0.000482	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—HSPB1—lung cancer	5.68e-05	0.000479	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.67e-05	0.000478	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—HSPB1—lung cancer	5.57e-05	0.00047	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—APC—lung cancer	5.57e-05	0.000469	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	5.5e-05	0.000464	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—NOTCH3—lung cancer	5.47e-05	0.000461	CbGpPWpGaD
Isotretinoin—RXRA—PPARA activates gene expression—EP300—lung cancer	5.47e-05	0.000461	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—GNG11—lung cancer	5.47e-05	0.000461	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.43e-05	0.000458	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CREBBP—lung cancer	5.41e-05	0.000456	CbGpPWpGaD
Isotretinoin—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—lung cancer	5.35e-05	0.000451	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—HSPB1—lung cancer	5.34e-05	0.00045	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—HSPB1—lung cancer	5.34e-05	0.00045	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—NCOA3—lung cancer	5.31e-05	0.000448	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—EIF2B5—lung cancer	5.3e-05	0.000447	CbGpPWpGaD
Isotretinoin—RXRG—Generic Transcription Pathway—CREBBP—lung cancer	5.23e-05	0.000441	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.21e-05	0.000439	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	5.19e-05	0.000437	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—JUNB—lung cancer	5.18e-05	0.000437	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	5.16e-05	0.000435	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PLBD1—lung cancer	5.15e-05	0.000434	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—CREBBP—lung cancer	5.13e-05	0.000433	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—NOTCH3—lung cancer	5.09e-05	0.000429	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—HPGDS—lung cancer	5.07e-05	0.000427	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.04e-05	0.000425	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—CDKN1A—lung cancer	5.03e-05	0.000424	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—NOTCH3—lung cancer	5.01e-05	0.000422	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	4.99e-05	0.000421	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	4.93e-05	0.000415	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—CREBBP—lung cancer	4.92e-05	0.000415	CbGpPWpGaD
Isotretinoin—RARA—Generic Transcription Pathway—CREBBP—lung cancer	4.92e-05	0.000415	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ADCY1—lung cancer	4.91e-05	0.000414	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCG2—lung cancer	4.91e-05	0.000414	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—NOTCH3—lung cancer	4.91e-05	0.000414	CbGpPWpGaD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.83e-05	0.000407	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—JUNB—lung cancer	4.82e-05	0.000407	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—DICER1—lung cancer	4.79e-05	0.000404	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—JUNB—lung cancer	4.74e-05	0.0004	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—HSD17B10—lung cancer	4.71e-05	0.000397	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—NOTCH3—lung cancer	4.71e-05	0.000397	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—NOTCH3—lung cancer	4.71e-05	0.000397	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—JUNB—lung cancer	4.65e-05	0.000392	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—TF—lung cancer	4.57e-05	0.000385	CbGpPWpGaD
Isotretinoin—RXRA—Adipogenesis—STAT3—lung cancer	4.49e-05	0.000378	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—JUNB—lung cancer	4.46e-05	0.000376	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—JUNB—lung cancer	4.46e-05	0.000376	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	4.39e-05	0.00037	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CKB—lung cancer	4.38e-05	0.000369	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	4.37e-05	0.000368	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	4.32e-05	0.000364	CbGpPWpGaD
Isotretinoin—RARB—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.25e-05	0.000358	CbGpPWpGaD
Isotretinoin—Haemorrhage—Methotrexate—lung cancer	4.23e-05	0.000187	CcSEcCtD
Isotretinoin—Hepatitis—Methotrexate—lung cancer	4.23e-05	0.000187	CcSEcCtD
Isotretinoin—Pollakiuria—Doxorubicin—lung cancer	4.23e-05	0.000187	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	4.23e-05	0.000356	CbGpPWpGaD
Isotretinoin—Asthenia—Gemcitabine—lung cancer	4.22e-05	0.000187	CcSEcCtD
Isotretinoin—Pain—Paclitaxel—lung cancer	4.21e-05	0.000186	CcSEcCtD
Isotretinoin—Constipation—Paclitaxel—lung cancer	4.21e-05	0.000186	CcSEcCtD
Isotretinoin—Confusional state—Docetaxel—lung cancer	4.2e-05	0.000186	CcSEcCtD
Isotretinoin—Pharyngitis—Methotrexate—lung cancer	4.2e-05	0.000186	CcSEcCtD
Isotretinoin—Urinary tract disorder—Methotrexate—lung cancer	4.18e-05	0.000185	CcSEcCtD
Isotretinoin—Photosensitivity reaction—Doxorubicin—lung cancer	4.18e-05	0.000185	CcSEcCtD
Isotretinoin—Anaphylactic shock—Docetaxel—lung cancer	4.17e-05	0.000185	CcSEcCtD
Isotretinoin—Oedema—Docetaxel—lung cancer	4.17e-05	0.000185	CcSEcCtD
Isotretinoin—Weight increased—Doxorubicin—lung cancer	4.16e-05	0.000184	CcSEcCtD
Isotretinoin—Pruritus—Gemcitabine—lung cancer	4.16e-05	0.000184	CcSEcCtD
Isotretinoin—Urethral disorder—Methotrexate—lung cancer	4.15e-05	0.000184	CcSEcCtD
Isotretinoin—Infection—Docetaxel—lung cancer	4.14e-05	0.000183	CcSEcCtD
Isotretinoin—Weight decreased—Doxorubicin—lung cancer	4.14e-05	0.000183	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—SKI—lung cancer	4.14e-05	0.000349	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Etoposide—lung cancer	4.13e-05	0.000183	CcSEcCtD
Isotretinoin—Diarrhoea—Irinotecan—lung cancer	4.13e-05	0.000183	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTM2—lung cancer	4.12e-05	0.000347	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CNDP2—lung cancer	4.12e-05	0.000347	CbGpPWpGaD
Isotretinoin—Pneumonia—Doxorubicin—lung cancer	4.1e-05	0.000182	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Etoposide—lung cancer	4.1e-05	0.000182	CcSEcCtD
Isotretinoin—Shock—Docetaxel—lung cancer	4.1e-05	0.000182	CcSEcCtD
Isotretinoin—Nervous system disorder—Docetaxel—lung cancer	4.09e-05	0.000181	CcSEcCtD
Isotretinoin—Thrombocytopenia—Docetaxel—lung cancer	4.08e-05	0.000181	CcSEcCtD
Isotretinoin—Infestation—Doxorubicin—lung cancer	4.08e-05	0.000181	CcSEcCtD
Isotretinoin—Infestation NOS—Doxorubicin—lung cancer	4.08e-05	0.000181	CcSEcCtD
Isotretinoin—Drowsiness—Doxorubicin—lung cancer	4.08e-05	0.000181	CcSEcCtD
Isotretinoin—RARA—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.08e-05	0.000344	CbGpPWpGaD
Isotretinoin—Visual impairment—Methotrexate—lung cancer	4.08e-05	0.000181	CcSEcCtD
Isotretinoin—Tachycardia—Docetaxel—lung cancer	4.07e-05	0.00018	CcSEcCtD
Isotretinoin—Feeling abnormal—Paclitaxel—lung cancer	4.05e-05	0.00018	CcSEcCtD
Isotretinoin—Skin disorder—Docetaxel—lung cancer	4.05e-05	0.000179	CcSEcCtD
Isotretinoin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	4.05e-05	0.000179	CcSEcCtD
Isotretinoin—Hypersensitivity—Cisplatin—lung cancer	4.04e-05	0.000179	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Paclitaxel—lung cancer	4.02e-05	0.000178	CcSEcCtD
Isotretinoin—Diarrhoea—Gemcitabine—lung cancer	4.02e-05	0.000178	CcSEcCtD
Isotretinoin—Renal failure—Doxorubicin—lung cancer	4.01e-05	0.000178	CcSEcCtD
Isotretinoin—RXRA—Metabolism—MTMR3—lung cancer	4.01e-05	0.000338	CbGpPWpGaD
Isotretinoin—Erythema multiforme—Methotrexate—lung cancer	4e-05	0.000177	CcSEcCtD
Isotretinoin—Neuropathy peripheral—Doxorubicin—lung cancer	4e-05	0.000177	CcSEcCtD
Isotretinoin—Dizziness—Irinotecan—lung cancer	3.99e-05	0.000177	CcSEcCtD
Isotretinoin—Urticaria—Etoposide—lung cancer	3.99e-05	0.000177	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—FOXO3—lung cancer	3.98e-05	0.000335	CbGpPWpGaD
Isotretinoin—Stomatitis—Doxorubicin—lung cancer	3.98e-05	0.000176	CcSEcCtD
Isotretinoin—Anorexia—Docetaxel—lung cancer	3.97e-05	0.000176	CcSEcCtD
Isotretinoin—Body temperature increased—Etoposide—lung cancer	3.97e-05	0.000176	CcSEcCtD
Isotretinoin—Abdominal pain—Etoposide—lung cancer	3.97e-05	0.000176	CcSEcCtD
Isotretinoin—Urinary tract infection—Doxorubicin—lung cancer	3.97e-05	0.000176	CcSEcCtD
Isotretinoin—Conjunctivitis—Doxorubicin—lung cancer	3.97e-05	0.000176	CcSEcCtD
Isotretinoin—Eye disorder—Methotrexate—lung cancer	3.95e-05	0.000175	CcSEcCtD
Isotretinoin—Tinnitus—Methotrexate—lung cancer	3.94e-05	0.000175	CcSEcCtD
Isotretinoin—Asthenia—Cisplatin—lung cancer	3.93e-05	0.000174	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	3.92e-05	0.000331	CbGpPWpGaD
Isotretinoin—Sweating—Doxorubicin—lung cancer	3.91e-05	0.000173	CcSEcCtD
Isotretinoin—Urticaria—Paclitaxel—lung cancer	3.91e-05	0.000173	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PGAM1—lung cancer	3.91e-05	0.000329	CbGpPWpGaD
Isotretinoin—Hypotension—Docetaxel—lung cancer	3.9e-05	0.000173	CcSEcCtD
Isotretinoin—Haematuria—Doxorubicin—lung cancer	3.89e-05	0.000172	CcSEcCtD
Isotretinoin—Body temperature increased—Paclitaxel—lung cancer	3.89e-05	0.000172	CcSEcCtD
Isotretinoin—Abdominal pain—Paclitaxel—lung cancer	3.89e-05	0.000172	CcSEcCtD
Isotretinoin—Epistaxis—Doxorubicin—lung cancer	3.85e-05	0.00017	CcSEcCtD
Isotretinoin—Angiopathy—Methotrexate—lung cancer	3.84e-05	0.00017	CcSEcCtD
Isotretinoin—Vomiting—Irinotecan—lung cancer	3.84e-05	0.00017	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—ITGB1—lung cancer	3.83e-05	0.000323	CbGpPWpGaD
Isotretinoin—Sinusitis—Doxorubicin—lung cancer	3.83e-05	0.00017	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	3.82e-05	0.000322	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	3.81e-05	0.000321	CbGpPWpGaD
Isotretinoin—Agranulocytosis—Doxorubicin—lung cancer	3.81e-05	0.000169	CcSEcCtD
Isotretinoin—Rash—Irinotecan—lung cancer	3.8e-05	0.000168	CcSEcCtD
Isotretinoin—Dermatitis—Irinotecan—lung cancer	3.8e-05	0.000168	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Docetaxel—lung cancer	3.8e-05	0.000168	CcSEcCtD
Isotretinoin—Chills—Methotrexate—lung cancer	3.8e-05	0.000168	CcSEcCtD
Isotretinoin—Headache—Irinotecan—lung cancer	3.78e-05	0.000167	CcSEcCtD
Isotretinoin—Insomnia—Docetaxel—lung cancer	3.77e-05	0.000167	CcSEcCtD
Isotretinoin—RARG—Gene Expression—ERCC2—lung cancer	3.76e-05	0.000317	CbGpPWpGaD
Isotretinoin—Diarrhoea—Cisplatin—lung cancer	3.75e-05	0.000166	CcSEcCtD
Isotretinoin—Paraesthesia—Docetaxel—lung cancer	3.74e-05	0.000166	CcSEcCtD
Isotretinoin—Alopecia—Methotrexate—lung cancer	3.74e-05	0.000166	CcSEcCtD
Isotretinoin—Vomiting—Gemcitabine—lung cancer	3.74e-05	0.000165	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CYP2A7—lung cancer	3.73e-05	0.000314	CbGpPWpGaD
Isotretinoin—Dyspnoea—Docetaxel—lung cancer	3.72e-05	0.000165	CcSEcCtD
Isotretinoin—Somnolence—Docetaxel—lung cancer	3.71e-05	0.000164	CcSEcCtD
Isotretinoin—Mental disorder—Methotrexate—lung cancer	3.71e-05	0.000164	CcSEcCtD
Isotretinoin—Rash—Gemcitabine—lung cancer	3.7e-05	0.000164	CcSEcCtD
Isotretinoin—Dermatitis—Gemcitabine—lung cancer	3.7e-05	0.000164	CcSEcCtD
Isotretinoin—Hypersensitivity—Etoposide—lung cancer	3.7e-05	0.000164	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	3.7e-05	0.000311	CbGpPWpGaD
Isotretinoin—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—lung cancer	3.69e-05	0.000311	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	3.69e-05	0.000311	CbGpPWpGaD
Isotretinoin—Malnutrition—Methotrexate—lung cancer	3.68e-05	0.000163	CcSEcCtD
Isotretinoin—Erythema—Methotrexate—lung cancer	3.68e-05	0.000163	CcSEcCtD
Isotretinoin—Haemoglobin—Doxorubicin—lung cancer	3.68e-05	0.000163	CcSEcCtD
Isotretinoin—Headache—Gemcitabine—lung cancer	3.68e-05	0.000163	CcSEcCtD
Isotretinoin—Dyspepsia—Docetaxel—lung cancer	3.67e-05	0.000163	CcSEcCtD
Isotretinoin—Hepatitis—Doxorubicin—lung cancer	3.66e-05	0.000162	CcSEcCtD
Isotretinoin—Haemorrhage—Doxorubicin—lung cancer	3.66e-05	0.000162	CcSEcCtD
Isotretinoin—RXRA—Metabolism—SDC4—lung cancer	3.65e-05	0.000307	CbGpPWpGaD
Isotretinoin—Hypoaesthesia—Doxorubicin—lung cancer	3.64e-05	0.000161	CcSEcCtD
Isotretinoin—Pharyngitis—Doxorubicin—lung cancer	3.64e-05	0.000161	CcSEcCtD
Isotretinoin—Decreased appetite—Docetaxel—lung cancer	3.62e-05	0.000161	CcSEcCtD
Isotretinoin—Hypersensitivity—Paclitaxel—lung cancer	3.62e-05	0.000161	CcSEcCtD
Isotretinoin—Urinary tract disorder—Doxorubicin—lung cancer	3.62e-05	0.00016	CcSEcCtD
Isotretinoin—Oedema peripheral—Doxorubicin—lung cancer	3.61e-05	0.00016	CcSEcCtD
Isotretinoin—Gastrointestinal disorder—Docetaxel—lung cancer	3.6e-05	0.000159	CcSEcCtD
Isotretinoin—Asthenia—Etoposide—lung cancer	3.6e-05	0.000159	CcSEcCtD
Isotretinoin—Fatigue—Docetaxel—lung cancer	3.6e-05	0.000159	CcSEcCtD
Isotretinoin—Urethral disorder—Doxorubicin—lung cancer	3.59e-05	0.000159	CcSEcCtD
Isotretinoin—Nausea—Irinotecan—lung cancer	3.58e-05	0.000159	CcSEcCtD
Isotretinoin—Pain—Docetaxel—lung cancer	3.57e-05	0.000158	CcSEcCtD
Isotretinoin—Constipation—Docetaxel—lung cancer	3.57e-05	0.000158	CcSEcCtD
Isotretinoin—Back pain—Methotrexate—lung cancer	3.56e-05	0.000158	CcSEcCtD
Isotretinoin—Pruritus—Etoposide—lung cancer	3.55e-05	0.000157	CcSEcCtD
Isotretinoin—Visual impairment—Doxorubicin—lung cancer	3.53e-05	0.000156	CcSEcCtD
Isotretinoin—Asthenia—Paclitaxel—lung cancer	3.53e-05	0.000156	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—HES1—lung cancer	3.53e-05	0.000297	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	3.52e-05	0.000296	CbGpPWpGaD
Isotretinoin—Nausea—Gemcitabine—lung cancer	3.49e-05	0.000155	CcSEcCtD
Isotretinoin—Vomiting—Cisplatin—lung cancer	3.48e-05	0.000154	CcSEcCtD
Isotretinoin—Pruritus—Paclitaxel—lung cancer	3.48e-05	0.000154	CcSEcCtD
Isotretinoin—Vision blurred—Methotrexate—lung cancer	3.47e-05	0.000154	CcSEcCtD
Isotretinoin—Erythema multiforme—Doxorubicin—lung cancer	3.46e-05	0.000153	CcSEcCtD
Isotretinoin—Rash—Cisplatin—lung cancer	3.45e-05	0.000153	CcSEcCtD
Isotretinoin—Dermatitis—Cisplatin—lung cancer	3.45e-05	0.000153	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—ERCC2—lung cancer	3.44e-05	0.00029	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Docetaxel—lung cancer	3.44e-05	0.000152	CcSEcCtD
Isotretinoin—Diarrhoea—Etoposide—lung cancer	3.43e-05	0.000152	CcSEcCtD
Isotretinoin—Eye disorder—Doxorubicin—lung cancer	3.42e-05	0.000152	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	3.42e-05	0.000288	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Methotrexate—lung cancer	3.42e-05	0.000151	CcSEcCtD
Isotretinoin—Tinnitus—Doxorubicin—lung cancer	3.42e-05	0.000151	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Docetaxel—lung cancer	3.41e-05	0.000151	CcSEcCtD
Isotretinoin—Anaemia—Methotrexate—lung cancer	3.4e-05	0.000151	CcSEcCtD
Isotretinoin—Flushing—Doxorubicin—lung cancer	3.4e-05	0.000151	CcSEcCtD
Isotretinoin—RARG—Generic Transcription Pathway—MYC—lung cancer	3.4e-05	0.000286	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—ERCC2—lung cancer	3.37e-05	0.000284	CbGpPWpGaD
Isotretinoin—Diarrhoea—Paclitaxel—lung cancer	3.37e-05	0.000149	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	3.33e-05	0.000281	CbGpPWpGaD
Isotretinoin—Angiopathy—Doxorubicin—lung cancer	3.32e-05	0.000147	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—RARB—lung cancer	3.32e-05	0.00028	CbGpPWpGaD
Isotretinoin—Malaise—Methotrexate—lung cancer	3.32e-05	0.000147	CcSEcCtD
Isotretinoin—RXRA—Metabolism—RRM1—lung cancer	3.32e-05	0.00028	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA3—lung cancer	3.32e-05	0.00028	CbGpPWpGaD
Isotretinoin—Dizziness—Etoposide—lung cancer	3.32e-05	0.000147	CcSEcCtD
Isotretinoin—Body temperature increased—Docetaxel—lung cancer	3.3e-05	0.000146	CcSEcCtD
Isotretinoin—Abdominal pain—Docetaxel—lung cancer	3.3e-05	0.000146	CcSEcCtD
Isotretinoin—Chills—Doxorubicin—lung cancer	3.29e-05	0.000146	CcSEcCtD
Isotretinoin—Arrhythmia—Doxorubicin—lung cancer	3.27e-05	0.000145	CcSEcCtD
Isotretinoin—Dizziness—Paclitaxel—lung cancer	3.25e-05	0.000144	CcSEcCtD
Isotretinoin—Nausea—Cisplatin—lung cancer	3.25e-05	0.000144	CcSEcCtD
Isotretinoin—Alopecia—Doxorubicin—lung cancer	3.24e-05	0.000143	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NPPA—lung cancer	3.24e-05	0.000273	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—ERCC2—lung cancer	3.24e-05	0.000273	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—ERCC2—lung cancer	3.24e-05	0.000273	CbGpPWpGaD
Isotretinoin—Cough—Methotrexate—lung cancer	3.21e-05	0.000142	CcSEcCtD
Isotretinoin—Mental disorder—Doxorubicin—lung cancer	3.21e-05	0.000142	CcSEcCtD
Isotretinoin—Convulsion—Methotrexate—lung cancer	3.19e-05	0.000141	CcSEcCtD
Isotretinoin—Vomiting—Etoposide—lung cancer	3.19e-05	0.000141	CcSEcCtD
Isotretinoin—Malnutrition—Doxorubicin—lung cancer	3.19e-05	0.000141	CcSEcCtD
Isotretinoin—Erythema—Doxorubicin—lung cancer	3.19e-05	0.000141	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—AVP—lung cancer	3.17e-05	0.000267	CbGpPWpGaD
Isotretinoin—Rash—Etoposide—lung cancer	3.16e-05	0.00014	CcSEcCtD
Isotretinoin—Dermatitis—Etoposide—lung cancer	3.16e-05	0.00014	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	3.15e-05	0.000266	CbGpPWpGaD
Isotretinoin—Headache—Etoposide—lung cancer	3.14e-05	0.000139	CcSEcCtD
Isotretinoin—Flatulence—Doxorubicin—lung cancer	3.14e-05	0.000139	CcSEcCtD
Isotretinoin—Chest pain—Methotrexate—lung cancer	3.14e-05	0.000139	CcSEcCtD
Isotretinoin—Myalgia—Methotrexate—lung cancer	3.14e-05	0.000139	CcSEcCtD
Isotretinoin—Arthralgia—Methotrexate—lung cancer	3.14e-05	0.000139	CcSEcCtD
Isotretinoin—RXRA—Adipogenesis—IL6—lung cancer	3.13e-05	0.000264	CbGpPWpGaD
Isotretinoin—Tension—Doxorubicin—lung cancer	3.13e-05	0.000139	CcSEcCtD
Isotretinoin—Vomiting—Paclitaxel—lung cancer	3.13e-05	0.000139	CcSEcCtD
Isotretinoin—RXRA—Metabolism—B4GALT5—lung cancer	3.12e-05	0.000263	CbGpPWpGaD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	3.11e-05	0.000138	CcSEcCtD
Isotretinoin—RXRG—Generic Transcription Pathway—MYC—lung cancer	3.11e-05	0.000262	CbGpPWpGaD
Isotretinoin—Rash—Paclitaxel—lung cancer	3.1e-05	0.000137	CcSEcCtD
Isotretinoin—Dermatitis—Paclitaxel—lung cancer	3.1e-05	0.000137	CcSEcCtD
Isotretinoin—Discomfort—Methotrexate—lung cancer	3.1e-05	0.000137	CcSEcCtD
Isotretinoin—Nervousness—Doxorubicin—lung cancer	3.1e-05	0.000137	CcSEcCtD
Isotretinoin—Back pain—Doxorubicin—lung cancer	3.08e-05	0.000137	CcSEcCtD
Isotretinoin—Headache—Paclitaxel—lung cancer	3.08e-05	0.000136	CcSEcCtD
Isotretinoin—Hypersensitivity—Docetaxel—lung cancer	3.07e-05	0.000136	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ABCB1—lung cancer	3.07e-05	0.000259	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	3.06e-05	0.000258	CbGpPWpGaD
Isotretinoin—RARB—Generic Transcription Pathway—MYC—lung cancer	3.05e-05	0.000257	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA4—lung cancer	3.04e-05	0.000256	CbGpPWpGaD
Isotretinoin—Confusional state—Methotrexate—lung cancer	3.03e-05	0.000134	CcSEcCtD
Isotretinoin—Anaphylactic shock—Methotrexate—lung cancer	3.01e-05	0.000133	CcSEcCtD
Isotretinoin—Vision blurred—Doxorubicin—lung cancer	3.01e-05	0.000133	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—FGFR1—lung cancer	3e-05	0.000253	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	3e-05	0.000253	CbGpPWpGaD
Isotretinoin—Asthenia—Docetaxel—lung cancer	2.99e-05	0.000132	CcSEcCtD
Isotretinoin—Infection—Methotrexate—lung cancer	2.99e-05	0.000132	CcSEcCtD
Isotretinoin—Nausea—Etoposide—lung cancer	2.98e-05	0.000132	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	2.97e-05	0.00025	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTA2—lung cancer	2.96e-05	0.000249	CbGpPWpGaD
Isotretinoin—Ill-defined disorder—Doxorubicin—lung cancer	2.96e-05	0.000131	CcSEcCtD
Isotretinoin—Pruritus—Docetaxel—lung cancer	2.95e-05	0.000131	CcSEcCtD
Isotretinoin—Nervous system disorder—Methotrexate—lung cancer	2.95e-05	0.000131	CcSEcCtD
Isotretinoin—Anaemia—Doxorubicin—lung cancer	2.95e-05	0.000131	CcSEcCtD
Isotretinoin—Thrombocytopenia—Methotrexate—lung cancer	2.94e-05	0.00013	CcSEcCtD
Isotretinoin—Agitation—Doxorubicin—lung cancer	2.93e-05	0.00013	CcSEcCtD
Isotretinoin—Nausea—Paclitaxel—lung cancer	2.92e-05	0.000129	CcSEcCtD
Isotretinoin—RARA—Generic Transcription Pathway—MYC—lung cancer	2.92e-05	0.000246	CbGpPWpGaD
Isotretinoin—RXRB—Generic Transcription Pathway—MYC—lung cancer	2.92e-05	0.000246	CbGpPWpGaD
Isotretinoin—Skin disorder—Methotrexate—lung cancer	2.92e-05	0.000129	CcSEcCtD
Isotretinoin—Hyperhidrosis—Methotrexate—lung cancer	2.91e-05	0.000129	CcSEcCtD
Isotretinoin—Malaise—Doxorubicin—lung cancer	2.88e-05	0.000127	CcSEcCtD
Isotretinoin—Anorexia—Methotrexate—lung cancer	2.86e-05	0.000127	CcSEcCtD
Isotretinoin—Syncope—Doxorubicin—lung cancer	2.86e-05	0.000127	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GSTA1—lung cancer	2.86e-05	0.000241	CbGpPWpGaD
Isotretinoin—Diarrhoea—Docetaxel—lung cancer	2.85e-05	0.000126	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	2.83e-05	0.000239	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KDR—lung cancer	2.83e-05	0.000238	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCC3—lung cancer	2.82e-05	0.000238	CbGpPWpGaD
Isotretinoin—Palpitations—Doxorubicin—lung cancer	2.82e-05	0.000125	CcSEcCtD
Isotretinoin—Hypotension—Methotrexate—lung cancer	2.81e-05	0.000124	CcSEcCtD
Isotretinoin—Loss of consciousness—Doxorubicin—lung cancer	2.8e-05	0.000124	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—HSPB1—lung cancer	2.78e-05	0.000235	CbGpPWpGaD
Isotretinoin—Cough—Doxorubicin—lung cancer	2.78e-05	0.000123	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MET—lung cancer	2.77e-05	0.000233	CbGpPWpGaD
Isotretinoin—Convulsion—Doxorubicin—lung cancer	2.76e-05	0.000122	CcSEcCtD
Isotretinoin—Dizziness—Docetaxel—lung cancer	2.76e-05	0.000122	CcSEcCtD
Isotretinoin—RARG—Gene Expression—CREBBP—lung cancer	2.75e-05	0.000232	CbGpPWpGaD
Isotretinoin—Hypertension—Doxorubicin—lung cancer	2.75e-05	0.000122	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Methotrexate—lung cancer	2.74e-05	0.000121	CcSEcCtD
Isotretinoin—RXRA—Metabolism—AKR1C1—lung cancer	2.73e-05	0.000231	CbGpPWpGaD
Isotretinoin—Insomnia—Methotrexate—lung cancer	2.72e-05	0.00012	CcSEcCtD
Isotretinoin—Arthralgia—Doxorubicin—lung cancer	2.71e-05	0.00012	CcSEcCtD
Isotretinoin—Myalgia—Doxorubicin—lung cancer	2.71e-05	0.00012	CcSEcCtD
Isotretinoin—Chest pain—Doxorubicin—lung cancer	2.71e-05	0.00012	CcSEcCtD
Isotretinoin—Anxiety—Doxorubicin—lung cancer	2.71e-05	0.00012	CcSEcCtD
Isotretinoin—Paraesthesia—Methotrexate—lung cancer	2.7e-05	0.00012	CcSEcCtD
Isotretinoin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	2.7e-05	0.000119	CcSEcCtD
Isotretinoin—Discomfort—Doxorubicin—lung cancer	2.68e-05	0.000119	CcSEcCtD
Isotretinoin—Dyspnoea—Methotrexate—lung cancer	2.68e-05	0.000119	CcSEcCtD
Isotretinoin—Somnolence—Methotrexate—lung cancer	2.67e-05	0.000118	CcSEcCtD
Isotretinoin—Dry mouth—Doxorubicin—lung cancer	2.66e-05	0.000118	CcSEcCtD
Isotretinoin—RXRA—Metabolism—UGT1A1—lung cancer	2.65e-05	0.000224	CbGpPWpGaD
Isotretinoin—Vomiting—Docetaxel—lung cancer	2.65e-05	0.000117	CcSEcCtD
Isotretinoin—Dyspepsia—Methotrexate—lung cancer	2.65e-05	0.000117	CcSEcCtD
Isotretinoin—Rash—Docetaxel—lung cancer	2.63e-05	0.000116	CcSEcCtD
Isotretinoin—Dermatitis—Docetaxel—lung cancer	2.63e-05	0.000116	CcSEcCtD
Isotretinoin—Confusional state—Doxorubicin—lung cancer	2.62e-05	0.000116	CcSEcCtD
Isotretinoin—Decreased appetite—Methotrexate—lung cancer	2.61e-05	0.000116	CcSEcCtD
Isotretinoin—Headache—Docetaxel—lung cancer	2.61e-05	0.000116	CcSEcCtD
Isotretinoin—Oedema—Doxorubicin—lung cancer	2.6e-05	0.000115	CcSEcCtD
Isotretinoin—Anaphylactic shock—Doxorubicin—lung cancer	2.6e-05	0.000115	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	2.6e-05	0.000219	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Methotrexate—lung cancer	2.59e-05	0.000115	CcSEcCtD
Isotretinoin—Fatigue—Methotrexate—lung cancer	2.59e-05	0.000115	CcSEcCtD
Isotretinoin—Infection—Doxorubicin—lung cancer	2.59e-05	0.000114	CcSEcCtD
Isotretinoin—Pain—Methotrexate—lung cancer	2.57e-05	0.000114	CcSEcCtD
Isotretinoin—RXRA—Generic Transcription Pathway—CREBBP—lung cancer	2.56e-05	0.000216	CbGpPWpGaD
Isotretinoin—Shock—Doxorubicin—lung cancer	2.56e-05	0.000113	CcSEcCtD
Isotretinoin—RXRA—Metabolism—GNG11—lung cancer	2.56e-05	0.000216	CbGpPWpGaD
Isotretinoin—Nervous system disorder—Doxorubicin—lung cancer	2.55e-05	0.000113	CcSEcCtD
Isotretinoin—Thrombocytopenia—Doxorubicin—lung cancer	2.55e-05	0.000113	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—APOA1—lung cancer	2.55e-05	0.000215	CbGpPWpGaD
Isotretinoin—Tachycardia—Doxorubicin—lung cancer	2.54e-05	0.000112	CcSEcCtD
Isotretinoin—Skin disorder—Doxorubicin—lung cancer	2.53e-05	0.000112	CcSEcCtD
Isotretinoin—RXRG—Gene Expression—CREBBP—lung cancer	2.52e-05	0.000212	CbGpPWpGaD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	2.52e-05	0.000212	CbGpPWpGaD
Isotretinoin—Hyperhidrosis—Doxorubicin—lung cancer	2.52e-05	0.000111	CcSEcCtD
Isotretinoin—Anorexia—Doxorubicin—lung cancer	2.48e-05	0.00011	CcSEcCtD
Isotretinoin—Nausea—Docetaxel—lung cancer	2.48e-05	0.00011	CcSEcCtD
Isotretinoin—Feeling abnormal—Methotrexate—lung cancer	2.48e-05	0.00011	CcSEcCtD
Isotretinoin—RARB—Gene Expression—CREBBP—lung cancer	2.47e-05	0.000208	CbGpPWpGaD
Isotretinoin—Gastrointestinal pain—Methotrexate—lung cancer	2.46e-05	0.000109	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—NOTCH3—lung cancer	2.45e-05	0.000207	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALDOA—lung cancer	2.44e-05	0.000205	CbGpPWpGaD
Isotretinoin—Hypotension—Doxorubicin—lung cancer	2.43e-05	0.000108	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—APOA1—lung cancer	2.42e-05	0.000204	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6R—lung cancer	2.42e-05	0.000204	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—CREBBP—lung cancer	2.41e-05	0.000203	CbGpPWpGaD
Isotretinoin—Urticaria—Methotrexate—lung cancer	2.39e-05	0.000106	CcSEcCtD
Isotretinoin—Abdominal pain—Methotrexate—lung cancer	2.38e-05	0.000105	CcSEcCtD
Isotretinoin—Body temperature increased—Methotrexate—lung cancer	2.38e-05	0.000105	CcSEcCtD
Isotretinoin—Musculoskeletal discomfort—Doxorubicin—lung cancer	2.37e-05	0.000105	CcSEcCtD
Isotretinoin—RARA—Gene Expression—CREBBP—lung cancer	2.37e-05	0.0002	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—CREBBP—lung cancer	2.37e-05	0.0002	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NCOA3—lung cancer	2.37e-05	0.000199	CbGpPWpGaD
Isotretinoin—Insomnia—Doxorubicin—lung cancer	2.35e-05	0.000104	CcSEcCtD
Isotretinoin—Paraesthesia—Doxorubicin—lung cancer	2.34e-05	0.000103	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	2.33e-05	0.000196	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—JUNB—lung cancer	2.32e-05	0.000196	CbGpPWpGaD
Isotretinoin—Dyspnoea—Doxorubicin—lung cancer	2.32e-05	0.000103	CcSEcCtD
Isotretinoin—Somnolence—Doxorubicin—lung cancer	2.31e-05	0.000102	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—MMP2—lung cancer	2.31e-05	0.000194	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAP2K1—lung cancer	2.3e-05	0.000194	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCG2—lung cancer	2.3e-05	0.000194	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ADCY1—lung cancer	2.3e-05	0.000194	CbGpPWpGaD
Isotretinoin—Dyspepsia—Doxorubicin—lung cancer	2.29e-05	0.000101	CcSEcCtD
Isotretinoin—Decreased appetite—Doxorubicin—lung cancer	2.26e-05	0.0001	CcSEcCtD
Isotretinoin—RXRA—Metabolism—HPGDS—lung cancer	2.26e-05	0.00019	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ENO2—lung cancer	2.26e-05	0.00019	CbGpPWpGaD
Isotretinoin—Gastrointestinal disorder—Doxorubicin—lung cancer	2.25e-05	9.95e-05	CcSEcCtD
Isotretinoin—Fatigue—Doxorubicin—lung cancer	2.24e-05	9.94e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—PPP2R1B—lung cancer	2.24e-05	0.000189	CbGpPWpGaD
Isotretinoin—Pain—Doxorubicin—lung cancer	2.23e-05	9.86e-05	CcSEcCtD
Isotretinoin—Constipation—Doxorubicin—lung cancer	2.23e-05	9.86e-05	CcSEcCtD
Isotretinoin—Hypersensitivity—Methotrexate—lung cancer	2.21e-05	9.81e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—POMC—lung cancer	2.21e-05	0.000187	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTT1—lung cancer	2.19e-05	0.000185	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GCLC—lung cancer	2.16e-05	0.000182	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP2A6—lung cancer	2.16e-05	0.000182	CbGpPWpGaD
Isotretinoin—Asthenia—Methotrexate—lung cancer	2.16e-05	9.55e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	2.16e-05	0.000182	CbGpPWpGaD
Isotretinoin—Feeling abnormal—Doxorubicin—lung cancer	2.14e-05	9.5e-05	CcSEcCtD
Isotretinoin—Gastrointestinal pain—Doxorubicin—lung cancer	2.13e-05	9.42e-05	CcSEcCtD
Isotretinoin—Pruritus—Methotrexate—lung cancer	2.13e-05	9.42e-05	CcSEcCtD
Isotretinoin—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	2.12e-05	0.000179	CbGpPWpGaD
Isotretinoin—Urticaria—Doxorubicin—lung cancer	2.07e-05	9.16e-05	CcSEcCtD
Isotretinoin—Body temperature increased—Doxorubicin—lung cancer	2.06e-05	9.11e-05	CcSEcCtD
Isotretinoin—Abdominal pain—Doxorubicin—lung cancer	2.06e-05	9.11e-05	CcSEcCtD
Isotretinoin—Diarrhoea—Methotrexate—lung cancer	2.06e-05	9.11e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—ENO1—lung cancer	2.05e-05	0.000173	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—CREBBP—lung cancer	2.05e-05	0.000173	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	2.04e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—RAF1—lung cancer	2.04e-05	0.000172	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—ERBB2—lung cancer	2.02e-05	0.00017	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—ALB—lung cancer	2.02e-05	0.00017	CbGpPWpGaD
Isotretinoin—Dizziness—Methotrexate—lung cancer	1.99e-05	8.8e-05	CcSEcCtD
Isotretinoin—RXRA—Transmembrane transport of small molecules—ALB—lung cancer	1.92e-05	0.000162	CbGpPWpGaD
Isotretinoin—Hypersensitivity—Doxorubicin—lung cancer	1.92e-05	8.49e-05	CcSEcCtD
Isotretinoin—Vomiting—Methotrexate—lung cancer	1.91e-05	8.46e-05	CcSEcCtD
Isotretinoin—Rash—Methotrexate—lung cancer	1.9e-05	8.39e-05	CcSEcCtD
Isotretinoin—Dermatitis—Methotrexate—lung cancer	1.89e-05	8.38e-05	CcSEcCtD
Isotretinoin—Headache—Methotrexate—lung cancer	1.88e-05	8.34e-05	CcSEcCtD
Isotretinoin—Asthenia—Doxorubicin—lung cancer	1.87e-05	8.27e-05	CcSEcCtD
Isotretinoin—Pruritus—Doxorubicin—lung cancer	1.84e-05	8.15e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—CYP2E1—lung cancer	1.84e-05	0.000155	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—NQO1—lung cancer	1.82e-05	0.000153	CbGpPWpGaD
Isotretinoin—Nausea—Methotrexate—lung cancer	1.79e-05	7.91e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	1.78e-05	0.00015	CbGpPWpGaD
Isotretinoin—Diarrhoea—Doxorubicin—lung cancer	1.78e-05	7.89e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	1.77e-05	0.000149	CbGpPWpGaD
Isotretinoin—RXRA—Transmembrane transport of small molecules—RAF1—lung cancer	1.74e-05	0.000146	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MMP9—lung cancer	1.73e-05	0.000146	CbGpPWpGaD
Isotretinoin—Dizziness—Doxorubicin—lung cancer	1.72e-05	7.62e-05	CcSEcCtD
Isotretinoin—RXRA—Gene Expression—ERCC2—lung cancer	1.69e-05	0.000142	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—MAPK3—lung cancer	1.68e-05	0.000142	CbGpPWpGaD
Isotretinoin—Vomiting—Doxorubicin—lung cancer	1.65e-05	7.33e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—EP300—lung cancer	1.64e-05	0.000139	CbGpPWpGaD
Isotretinoin—Rash—Doxorubicin—lung cancer	1.64e-05	7.27e-05	CcSEcCtD
Isotretinoin—RXRA—Metabolism—STK11—lung cancer	1.64e-05	0.000138	CbGpPWpGaD
Isotretinoin—Dermatitis—Doxorubicin—lung cancer	1.64e-05	7.26e-05	CcSEcCtD
Isotretinoin—RARG—Gene Expression—MYC—lung cancer	1.64e-05	0.000138	CbGpPWpGaD
Isotretinoin—Headache—Doxorubicin—lung cancer	1.63e-05	7.22e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—SRC—lung cancer	1.6e-05	0.000135	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—VEGFA—lung cancer	1.56e-05	0.000131	CbGpPWpGaD
Isotretinoin—Nausea—Doxorubicin—lung cancer	1.55e-05	6.85e-05	CcSEcCtD
Isotretinoin—RXRA—Developmental Biology—STAT3—lung cancer	1.54e-05	0.00013	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PTEN—lung cancer	1.54e-05	0.00013	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—NRAS—lung cancer	1.54e-05	0.00013	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MAPK3—lung cancer	1.54e-05	0.00013	CbGpPWpGaD
Isotretinoin—RXRA—Generic Transcription Pathway—MYC—lung cancer	1.52e-05	0.000128	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTP1—lung cancer	1.52e-05	0.000128	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MAPK3—lung cancer	1.51e-05	0.000127	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—MYC—lung cancer	1.5e-05	0.000126	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CAT—lung cancer	1.48e-05	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—MAPK3—lung cancer	1.47e-05	0.000124	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—EP300—lung cancer	1.47e-05	0.000124	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—MYC—lung cancer	1.47e-05	0.000124	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MAPK3—lung cancer	1.45e-05	0.000122	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MAPK3—lung cancer	1.45e-05	0.000122	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ABCB1—lung cancer	1.44e-05	0.000121	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—TYMS—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—MYC—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—MYC—lung cancer	1.41e-05	0.000119	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—EGFR—lung cancer	1.4e-05	0.000118	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—GSTM1—lung cancer	1.39e-05	0.000118	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—KRAS—lung cancer	1.32e-05	0.000112	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CYP1A1—lung cancer	1.32e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ERCC2—lung cancer	1.31e-05	0.000111	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—CREBBP—lung cancer	1.23e-05	0.000104	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—APOA1—lung cancer	1.13e-05	9.56e-05	CbGpPWpGaD
Isotretinoin—RARG—Gene Expression—AKT1—lung cancer	1.13e-05	9.56e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—HRAS—lung cancer	1.13e-05	9.48e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	1.09e-05	9.16e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—IL6—lung cancer	1.08e-05	9.08e-05	CbGpPWpGaD
Isotretinoin—RXRG—Gene Expression—AKT1—lung cancer	1.04e-05	8.74e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CG—lung cancer	1.04e-05	8.73e-05	CbGpPWpGaD
Isotretinoin—RARB—Gene Expression—AKT1—lung cancer	1.02e-05	8.57e-05	CbGpPWpGaD
Isotretinoin—RXRA—Developmental Biology—AKT1—lung cancer	9.93e-06	8.37e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—POMC—lung cancer	9.86e-06	8.31e-05	CbGpPWpGaD
Isotretinoin—RXRB—Gene Expression—AKT1—lung cancer	9.75e-06	8.22e-05	CbGpPWpGaD
Isotretinoin—RARA—Gene Expression—AKT1—lung cancer	9.75e-06	8.22e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—CREBBP—lung cancer	9.6e-06	8.09e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CD—lung cancer	9.1e-06	7.67e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—ALB—lung cancer	8.99e-06	7.58e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CB—lung cancer	7.93e-06	6.69e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTGS2—lung cancer	7.86e-06	6.63e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MAPK3—lung cancer	7.53e-06	6.35e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—MYC—lung cancer	7.33e-06	6.18e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PTEN—lung cancer	6.86e-06	5.78e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—EP300—lung cancer	6.54e-06	5.51e-05	CbGpPWpGaD
Isotretinoin—RXRA—Gene Expression—AKT1—lung cancer	5.08e-06	4.28e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—PIK3CA—lung cancer	4.84e-06	4.08e-05	CbGpPWpGaD
Isotretinoin—RXRA—Metabolism—AKT1—lung cancer	3.95e-06	3.33e-05	CbGpPWpGaD
